Prescribing trends of glaucoma medication in Korea from 2007 to 2020: A nationwide population-based study.

Authors: Na, Kyeong Ik¹ (AUTHOR), Lee, Won June² (AUTHOR), Choi, Youn Joo¹ (AUTHOR) ophdrchoi@gmail.com, Park, Sung Pyo¹ (AUTHOR) ophdrchoi@gmail.com

Source: PLoS ONE. 7/11/2024, Vol. 19 Issue 7, p1-18. 18p.

Subject Terms: *BIMATOPROST, *EYE drops, *GLAUCOMA, *CARBONIC anhydrase inhibitors, *DRUGS

Bimatoprost Can Increase Growth and Density of Eyebrow Hair: A Prospective Study on a Group of Young Women.

Authors: Załęcki, Piotr¹, Skakowska, Justyna¹, Nowicka, Danuta^1,2, danuta.nowicka@umw.edu.pl

Source: Applied Sciences (2076-3417); Jul2024, Vol. 14 Issue 13, p5848, 12p

The role of fractional laser‐assisted drug delivery in enhancing the efficacy of topical bimatoprost solution in the treatment of alopecia areata: An intra‐patient comparative randomized clinical trial.

Authors: Meymandi, Simin Shamsi¹ (AUTHOR), Safari, Alireza² (AUTHOR), Meymandi, Manzumeh Shamsi¹ (AUTHOR), Aflatoonian, Mahin¹ (AUTHOR) maaflatoonian@gmail.com

Source: Journal of Cosmetic Dermatology. May2024, Vol. 23 Issue 5, p1663-1668. 6p.

Subject Terms: *ALOPECIA areata, *BIMATOPROST, *CLINICAL trials, *CARBON dioxide lasers, *HAIR analysis, *HAIR transplantation, *DRUG efficacy, *PATIENT satisfaction

The efficacy of bimatoprost ophthalmic solution combined with NB-UVB phototherapy in non-segmental and segmental vitiligo: a single-blind randomized controlled study.

Authors: Silpa-archa, Narumol¹ (AUTHOR), Likittanasombat, Surachanee¹ (AUTHOR), Apinuntham, Chalermkwan¹ (AUTHOR), Pruksaeakanan, Chutipon¹ (AUTHOR), Charoenpipatsin, Norramon¹ (AUTHOR), Chaiyabutr, Chayada¹ (AUTHOR), Wongpraparut, Chanisada¹ (AUTHOR) chanisada@hotmail.com

Source: Scientific Reports. 4/20/2023, Vol. 13 Issue 1, p1-9. 9p.

Subject Terms: *VITILIGO, *BIMATOPROST, *THAI people, *PHOTOTHERAPY, *OPHTHALMIC drugs, *TREATMENT duration

Bimatoprost versus clobetasol propionate in scalp alopecia areata: A prospective non-randomized open-label clinical trial.

Authors: Bhusal, Mohan¹ (AUTHOR), Bhattarai, Sabina² (AUTHOR), Thapa, Binita³ (AUTHOR), Shrestha, Prashanna⁴ (AUTHOR), Sagar, G⁴ (AUTHOR)

Source: Indian Dermatology Online Journal. Mar/Apr2023, Vol. 14 Issue 2, p221-225. 5p.

Subject Terms: *CLOBETASOL, *BIMATOPROST, *ALOPECIA areata, *SCALP, *CLINICAL trials, *HAIR transplantation, *ACTINIC keratosis, *ORAL medication, *HAIR removal

Geographic Terms: NEPAL

Periocular invasive melanoma manifestation in a patient using bimatoprost: case report and literature review.

Authors: Deveau, Adam P.¹ (AUTHOR), da Silva, Flávia Nagel² (AUTHOR), Ly, Thai Yen³ (AUTHOR), Hussain, Ahsen⁴ (AUTHOR) ahsen@dal.ca

Source: Orbit. Feb2023, Vol. 42 Issue 1, p73-80. 8p.

Subject Terms: *BIMATOPROST, *MELANOMA, *OPEN-angle glaucoma, *EYE drops, *LENTIGO

Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo.

Authors: Zaky, Mohamed S.¹ (AUTHOR), Atallah, Rabie B.¹ (AUTHOR), El Abasy, Nada Taha, Ali² (AUTHOR), Elsaie, Mohamed L.³ (AUTHOR) Egydoc77@yahoo.com

Source: Archives of Dermatological Research. Sep2024, Vol. 316 Issue 7, p1-8. 8p.

Subject Terms: *BIMATOPROST, *VITILIGO, *TACROLIMUS, *PIGMENTATION disorders, *END of treatment

Topical Bimatoprost (0.03%) Versus Topical Mometasone Furoate (0.1%) in Treatment of Alopecia Areata.

Authors: Iram, Ayasha¹ ayashairam29@gmail.com, Tahir, Raheel¹, Akhtar, Aliya¹, Mariam, Madiha¹, Zafar, Zahra²

Source: Annals of King Edward Medical University. Jan-Mar2023, Vol. 29 Issue 1, p44-49. 6p.

Subject Terms: *ALOPECIA areata, *BIMATOPROST, *HAIR growth, *PATIENT satisfaction, *HAIR follicles, *CLINICAL trials

Cytotoxicity, Mitochondrial Functionality, and Redox Status of Human Conjunctival Cells after Short and Chronic Exposure to Preservative-Free Bimatoprost 0.03% and 0.01%: An In Vitro Comparative Study.

Authors: Petricca, Sabrina¹ (AUTHOR), Celenza, Giuseppe¹ (AUTHOR) giuseppe.celenza@univaq.it, Costagliola, Ciro² (AUTHOR), Tranfa, Fausto² (AUTHOR), Iorio, Roberto¹ (AUTHOR)

Source: International Journal of Molecular Sciences. Nov2022, Vol. 23 Issue 22, p14113. 16p.

Subject Terms: *BIMATOPROST, *CELL cycle, *MITOCHONDRIA, *REACTIVE oxygen species, *MEMBRANE potential

A Randomized Controlled Clinical Trial to Compare Conventional Drug Instillation to A Device Dropper Method in Medical Treatment of Glaucoma.

Authors: Rajendrababu, Sharmila¹ (AUTHOR), Kannan, Shalini¹ (AUTHOR), More, Shilpa¹ (AUTHOR) moreshilpa295@gmail.com, Sithiq, Mohammed Uduman S¹ (AUTHOR), Krishnadas, Subbaiah Ramasamy¹ (AUTHOR)

Source: Ophthalmic Epidemiology. Aug2022, Vol. 29 Issue 4, p452-459. 8p.

Subject Terms: *BIMATOPROST, *DRUG instillation, *CLINICAL trials, *RANDOMIZED controlled trials, *THERAPEUTICS, *OPEN-angle glaucoma

Many human pharmaceuticals are weak inhibitors of the cytochrome P450 system in rainbow trout (Oncorhynchus mykiss) liver S9 fractions.

Authors: Pihlaja, Tea^1,2, Oksanen, Timo¹, Vinkvist, Netta¹, Sikanen, Tiina^1,2, tiina.sikanen@helsinki.fi

Source: Frontiers in Toxicology; 2024, p1-13, 13p

Improving medication adherence in glaucoma patients: a randomized controlled interventional study.

Authors: Barakat, Noor A^1,2 (AUTHOR), AlGhanem, Rama¹ (AUTHOR), Abdulrazeq, Bashar¹ (AUTHOR), AlKhatib, Hatim S¹ (AUTHOR), AlRyalat, Saif Aldeen³ (AUTHOR), Muhsen, Sana'³ (AUTHOR), AlMuhaissen, Suha¹ (AUTHOR) s.muhaissen@ju.edu.jo

Source: Journal of Pharmaceutical Health Services Research. Jun2024, Vol. 15 Issue 2, p1-9. 9p.

Subject Terms: *EYE drops, *BIMATOPROST, *CLINICAL trials, *PATIENT compliance, *INTRAOCULAR drug administration, *DRUG side effects, *OPEN-angle glaucoma

Geographic Terms: JORDAN

Bimatoprost SR for Glaucoma Therapy Implanted at the Slit-Lamp in a Real-World Setting.

Authors: Ali, Arsalan Akbar (AUTHOR), Elescano, Denisse Avilés (AUTHOR), Grover, Davinder S (AUTHOR)

Source: Clinical Ophthalmology. May2024, Vol. 18, p1371-1377. 7p.

Subject Terms: *BIMATOPROST, *GLAUCOMA, *SLIT lamp microscopy, *INTRAOCULAR pressure, *SURVIVAL rate

Geographic Terms: DALLAS (Tex.), TEXAS

Prospective 18-Month Study of Bimatoprost Intracameral Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension in US Clinical Practice: Effectiveness and Safety of the Bimatoprost Implant: E. Mann et al.

Authors: Mann, Eric, Kammer, Jeffrey A., Sawhney, Gagan, An, Jella, Werts, Erica C., Vera, Vanessa, Rivas, Marcos, Lai, Hongxin, Sonparote, Sadhana, Craven, E. Randy

Source: Drugs; Mar2025, Vol. 85 Issue 3, p397-414, 18p

Subject Terms: GLAUCOMA, OCULAR hypertension, PATIENT safety, RESEARCH funding, INTRAOCULAR drug administration, CLINICAL trials, SCIENTIFIC observation, INTERVIEWING, BIMATOPROST, INJECTIONS, LONGITUDINAL method, DRUG efficacy, RESEARCH, BIODEGRADABLE materials, CONFIDENCE intervals, PATIENT satisfaction, CONTROLLED release drugs, PATIENT aftercare, DRUG dosage, EVALUATION, DRUG administration

Real-World Analysis of the Efficacy of Bimatoprost Sustained-Release Glaucoma Implant Where American Indians Comprise the Largest Minority Population.

Authors: Jr, Steven R Sarkisian (AUTHOR), Mitchell, Evann C (AUTHOR)

Source: Clinical Ophthalmology. Mar2024, Vol. 18, p917-927. 11p.

Subject Terms: *BIMATOPROST, *GLAUCOMA, *OCULAR hypertension, *INTRAOCULAR pressure, *OPEN-angle glaucoma

Analysis of the Responsiveness of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in the Treatment of OAG/OHT Patients.

Authors: Cai, Ziyan¹ (AUTHOR), Cao, Mengdan¹ (AUTHOR), Liu, Ke¹ (AUTHOR), Duan, Xuanchu² (AUTHOR)

Source: Journal of Ophthalmology. 5/25/2021, p1-12. 12p.

Subject Terms: *BIMATOPROST, *PROSTAGLANDINS, *ONLINE information services, *GLAUCOMA, *META-analysis, *MEDICAL information storage & retrieval systems, *INFORMATION storage & retrieval systems, *MEDICAL databases, *OCULAR hypertension, *SYSTEMATIC reviews, *HEALTH outcome assessment, *OPHTHALMIC drugs, *TRAVOPROST, *DISEASE prevalence, *MEDLINE, *DRUG side effects, *PATIENT safety, *PHARMACODYNAMICS

High Correlation between Glaucoma Treatment with Topical Prostaglandin Analogs and BDNF Immunoreactivity in Human Retina.

Authors: Harper, Matthew M.^1,2 (AUTHOR) matthew-harper@uiowa.edu, Boese, Erin A.¹ (AUTHOR), Kardon, Randy H.^1,2 (AUTHOR), Ledolter, Johannes^2,3 (AUTHOR), Kuehn, Markus H.^1,2 (AUTHOR)

Source: Current Eye Research. May2021, Vol. 46 Issue 5, p739-745. 7p.

Subject Terms: *BIMATOPROST, *BRAIN-derived neurotrophic factor, *RETINAL ganglion cells, *RETINA, *PROSTAGLANDINS, *CARBONIC anhydrase inhibitors

Systemic adverse drug events to topical prostaglandin analogs for treating glaucoma: a retrospective focused pharmacovigilance study

Authors: Kannan Sridharan

Source: BMC Ophthalmology, Vol 24, Iss 1, Pp 1-12 (2024)

Subject Terms: Latanoprost, Bimatoprost, Travoprost, Tafluprost, Latanoprostene bunod, Ophthalmology, RE1-994

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2415

Access URL: https://doaj.org/article/fb019e84aea24df494b224d791284db3

Clinical outcomes of topical bimatoprost for nonsegmental facial vitiligo: A preliminary study.

Authors: Kanokrungsee, Silada^1,2 (AUTHOR), Pruettivorawongse, Duangrat¹ (AUTHOR), Rajatanavin, Natta¹ (AUTHOR) natta.rama@gmail.com

Source: Journal of Cosmetic Dermatology. Mar2021, Vol. 20 Issue 3, p812-818. 7p.

Subject Terms: *TREATMENT effectiveness, *BIMATOPROST, *VITILIGO, *OPHTHALMIC drugs, *INTRAOCULAR pressure, *FACIAL transplantation, *TONOMETERS

First-line glaucoma monotherapy medication patterns in Finland during 1995–2019 based on a population-based study.

Authors: Purola, Petri K. M., Koskinen, Seppo V. P., Uusitalo, Hannu M. T.

Source: PLoS ONE; 1/30/2025, Vol. 20 Issue 1, p1-16, 16p

Subject Terms: PERIODIC health examinations, DRUG therapy, GLAUCOMA, TIMOLOL maleate, INFORMATION storage & retrieval systems, BIMATOPROST